ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,482 | -23.9% | 31,922 | +11.1% | 0.00% | -33.3% |
| Q2 2023 | $84,730 | -21.1% | 28,722 | -33.1% | 0.01% | 0.0% |
| Q1 2023 | $107,393 | -46.0% | 42,957 | -31.5% | 0.01% | -40.0% |
| Q4 2022 | $198,829 | +9.2% | 62,722 | +2.5% | 0.01% | +42.9% |
| Q3 2022 | $182,000 | +87.6% | 61,222 | +92.5% | 0.01% | +133.3% |
| Q2 2022 | $97,000 | -34.9% | 31,800 | +189.1% | 0.00% | -25.0% |
| Q1 2022 | $149,000 | +52.0% | 11,000 | +5.8% | 0.00% | +33.3% |
| Q3 2021 | $98,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |